Patent details
EP3853200 Title: ERBUMINE SALT OF TREPROSTINIL
Basic Information
- Publication number:
- EP3853200
- PCT Application Number:
- US2019050632
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP197736952
- PCT Publication Number:
- WO2020060823
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ERBUMINE SALT OF TREPROSTINIL
- French Title of Invention:
- LE SEL ERBUMINE DU TREPROSTINIL
- German Title of Invention:
- ERBUMINE SALZ VON TREPROSTINIL
- SPC Number:
Dates
- Filing date:
- 11/09/2019
- Grant date:
- 24/01/2024
- EP Publication Date:
- 28/07/2021
- PCT Publication Date:
- 26/03/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 24/01/2024
- EP B1 Publication Date:
- 24/01/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 11/09/2024
- Expiration date:
- 11/09/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 17/01/2024
- Name:
- Eli Lilly and Company
- Address:
- Lilly Corporate Center, Indianapolis, IN 46285, United States (US)
Inventor
- Name:
- REMICK, David Michael
- Address:
- United States (US)
Priority
- Priority Number:
- 201862732799 P
- Priority Date:
- 18/09/2018
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07C 51/43; C07C 59/70; A61K 38/28; A61K 31/5575; A61P 3/10; A61P 9/08;
Publication
European Patent Bulletin
- Issue number:
- 202404
- Publication date:
- 24/01/2024
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|